2025-06-012026-05-312026-05-31false12632649ED ROWE MEDICAL LIMITED2026-10-0886210falseiso4217:GBPxbrli:pure126326492025-05-31126326492026-05-31126326492025-06-012026-05-31126326492024-05-31126326492025-05-31126326492024-06-012025-05-3112632649bus:SmallEntities2025-06-012026-05-3112632649bus:AuditExempt-NoAccountantsReport2025-06-012026-05-3112632649bus:AbridgedAccounts2025-06-012026-05-3112632649bus:PrivateLimitedCompanyLtd2025-06-012026-05-3112632649core:WithinOneYear2026-05-3112632649core:AfterOneYear2026-05-3112632649core:WithinOneYear2025-05-3112632649core:AfterOneYear2025-05-3112632649core:ShareCapital2026-05-3112632649core:SharePremium2026-05-3112632649core:RevaluationReserve2026-05-3112632649core:OtherReservesSubtotal2026-05-3112632649core:RetainedEarningsAccumulatedLosses2026-05-3112632649core:ShareCapital2025-05-3112632649core:SharePremium2025-05-3112632649core:RevaluationReserve2025-05-3112632649core:OtherReservesSubtotal2025-05-3112632649core:RetainedEarningsAccumulatedLosses2025-05-3112632649core:LandBuildings2026-05-3112632649core:PlantMachinery2026-05-3112632649core:Vehicles2026-05-3112632649core:FurnitureFittings2026-05-3112632649core:OfficeEquipment2026-05-3112632649core:NetGoodwill2026-05-3112632649core:IntangibleAssetsOtherThanGoodwill2026-05-3112632649core:ListedExchangeTraded2026-05-3112632649core:UnlistedNon-exchangeTraded2026-05-3112632649core:LandBuildings2025-05-3112632649core:PlantMachinery2025-05-3112632649core:Vehicles2025-05-3112632649core:FurnitureFittings2025-05-3112632649core:OfficeEquipment2025-05-3112632649core:NetGoodwill2025-05-3112632649core:IntangibleAssetsOtherThanGoodwill2025-05-3112632649core:ListedExchangeTraded2025-05-3112632649core:UnlistedNon-exchangeTraded2025-05-3112632649core:LandBuildings2025-06-012026-05-3112632649core:PlantMachinery2025-06-012026-05-3112632649core:Vehicles2025-06-012026-05-3112632649core:FurnitureFittings2025-06-012026-05-3112632649core:OfficeEquipment2025-06-012026-05-3112632649core:NetGoodwill2025-06-012026-05-3112632649core:IntangibleAssetsOtherThanGoodwill2025-06-012026-05-3112632649core:ListedExchangeTraded2025-06-012026-05-3112632649core:UnlistedNon-exchangeTraded2025-06-012026-05-3112632649core:MoreThanFiveYears2025-06-012026-05-3112632649core:Non-currentFinancialInstruments2026-05-3112632649core:Non-currentFinancialInstruments2025-05-3112632649dpl:CostSales2025-06-012026-05-3112632649dpl:DistributionCosts2025-06-012026-05-3112632649core:LandBuildings2025-06-012026-05-3112632649core:PlantMachinery2025-06-012026-05-3112632649core:Vehicles2025-06-012026-05-3112632649core:FurnitureFittings2025-06-012026-05-3112632649core:OfficeEquipment2025-06-012026-05-3112632649dpl:AdministrativeExpenses2025-06-012026-05-3112632649core:NetGoodwill2025-06-012026-05-3112632649core:IntangibleAssetsOtherThanGoodwill2025-06-012026-05-3112632649dpl:GroupUndertakings2025-06-012026-05-3112632649dpl:ParticipatingInterests2025-06-012026-05-3112632649dpl:GroupUndertakingscore:ListedExchangeTraded2025-06-012026-05-3112632649core:ListedExchangeTraded2025-06-012026-05-3112632649dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-06-012026-05-3112632649core:UnlistedNon-exchangeTraded2025-06-012026-05-3112632649dpl:CostSales2024-06-012025-05-3112632649dpl:DistributionCosts2024-06-012025-05-3112632649core:LandBuildings2024-06-012025-05-3112632649core:PlantMachinery2024-06-012025-05-3112632649core:Vehicles2024-06-012025-05-3112632649core:FurnitureFittings2024-06-012025-05-3112632649core:OfficeEquipment2024-06-012025-05-3112632649dpl:AdministrativeExpenses2024-06-012025-05-3112632649core:NetGoodwill2024-06-012025-05-3112632649core:IntangibleAssetsOtherThanGoodwill2024-06-012025-05-3112632649dpl:GroupUndertakings2024-06-012025-05-3112632649dpl:ParticipatingInterests2024-06-012025-05-3112632649dpl:GroupUndertakingscore:ListedExchangeTraded2024-06-012025-05-3112632649core:ListedExchangeTraded2024-06-012025-05-3112632649dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-06-012025-05-3112632649core:UnlistedNon-exchangeTraded2024-06-012025-05-3112632649core:NetGoodwill2026-05-3112632649core:IntangibleAssetsOtherThanGoodwill2026-05-3112632649core:LandBuildings2026-05-3112632649core:PlantMachinery2026-05-3112632649core:Vehicles2026-05-3112632649core:FurnitureFittings2026-05-3112632649core:OfficeEquipment2026-05-3112632649core:AfterOneYear2026-05-3112632649core:WithinOneYear2026-05-3112632649core:ListedExchangeTraded2026-05-3112632649core:UnlistedNon-exchangeTraded2026-05-3112632649core:ShareCapital2026-05-3112632649core:SharePremium2026-05-3112632649core:RevaluationReserve2026-05-3112632649core:OtherReservesSubtotal2026-05-3112632649core:RetainedEarningsAccumulatedLosses2026-05-3112632649core:NetGoodwill2025-05-3112632649core:IntangibleAssetsOtherThanGoodwill2025-05-3112632649core:LandBuildings2025-05-3112632649core:PlantMachinery2025-05-3112632649core:Vehicles2025-05-3112632649core:FurnitureFittings2025-05-3112632649core:OfficeEquipment2025-05-3112632649core:AfterOneYear2025-05-3112632649core:WithinOneYear2025-05-3112632649core:ListedExchangeTraded2025-05-3112632649core:UnlistedNon-exchangeTraded2025-05-3112632649core:ShareCapital2025-05-3112632649core:SharePremium2025-05-3112632649core:RevaluationReserve2025-05-3112632649core:OtherReservesSubtotal2025-05-3112632649core:RetainedEarningsAccumulatedLosses2025-05-3112632649core:NetGoodwill2024-05-3112632649core:IntangibleAssetsOtherThanGoodwill2024-05-3112632649core:LandBuildings2024-05-3112632649core:PlantMachinery2024-05-3112632649core:Vehicles2024-05-3112632649core:FurnitureFittings2024-05-3112632649core:OfficeEquipment2024-05-3112632649core:AfterOneYear2024-05-3112632649core:WithinOneYear2024-05-3112632649core:ListedExchangeTraded2024-05-3112632649core:UnlistedNon-exchangeTraded2024-05-3112632649core:ShareCapital2024-05-3112632649core:SharePremium2024-05-3112632649core:RevaluationReserve2024-05-3112632649core:OtherReservesSubtotal2024-05-3112632649core:RetainedEarningsAccumulatedLosses2024-05-3112632649core:AfterOneYear2025-06-012026-05-3112632649core:WithinOneYear2025-06-012026-05-3112632649core:Non-currentFinancialInstrumentscore:CostValuation2025-06-012026-05-3112632649core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-06-012026-05-3112632649core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-06-012026-05-3112632649core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-06-012026-05-3112632649core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-06-012026-05-3112632649core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-06-012026-05-3112632649core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-06-012026-05-3112632649core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-06-012026-05-3112632649core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-06-012026-05-3112632649core:Non-currentFinancialInstrumentscore:CostValuation2026-05-3112632649core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-05-3112632649core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-05-3112632649core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-05-3112632649core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-05-3112632649core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-05-3112632649core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-05-3112632649core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-05-3112632649core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-05-3112632649core:Non-currentFinancialInstrumentscore:CostValuation2025-05-3112632649core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-05-3112632649core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-05-3112632649core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-05-3112632649core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-05-3112632649core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-05-3112632649core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-05-3112632649core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-05-3112632649core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-05-3112632649bus:Director12025-06-012026-05-31

ED ROWE MEDICAL LIMITED

Registered Number
12632649
(England and Wales)

Unaudited Financial Statements for the Year ended
31 May 2026

ED ROWE MEDICAL LIMITED
Company Information
for the year from 1 June 2025 to 31 May 2026

Director

ROWE, Edward William, Dr

Registered Address

Building 2a, D Site Kemble Airfield
Kemble
Cirencester
GL7 6BA

Registered Number

12632649 (England and Wales)
ED ROWE MEDICAL LIMITED
Balance Sheet as at
31 May 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Tangible assets33141
3141
Current assets
Debtors416,06522,993
Current asset investments720,000-
Cash at bank and on hand355,427920,696
1,091,492943,689
Creditors amounts falling due within one year5(66,340)(90,122)
Net current assets (liabilities)1,025,152853,567
Total assets less current liabilities1,025,183853,608
Net assets1,025,183853,608
Capital and reserves
Called up share capital11
Profit and loss account1,025,182853,607
Shareholders' funds1,025,183853,608
The financial statements were approved and authorised for issue by the Director on 8 October 2026, and are signed on its behalf by:
ROWE, Edward William, Dr
Director
Registered Company No. 12632649
ED ROWE MEDICAL LIMITED
Notes to the Financial Statements
for the year ended 31 May 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
2.Average number of employees

20262025
Average number of employees during the year11
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 June 25173
At 31 May 26173
Depreciation and impairment
At 01 June 25132
Charge for year10
At 31 May 26142
Net book value
At 31 May 2631
At 31 May 2541
4.Debtors: amounts due within one year

2026

2025

££
Trade debtors / trade receivables16,06522,993
Total16,06522,993
5.Creditors: amounts due within one year

2026

2025

££
Taxation and social security56,94179,234
Other creditors4,7906,046
Accrued liabilities and deferred income4,6094,842
Total66,34090,122